Assessment of the Adminstration of Low Molecular Weight Heparin for Hemodialysis Anticoagulation in Comparison to Standard Unfractionated Heparin
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 6, Issue 9
Abstract
Background and Aim of Study: The use of Low-molecular-weight heparin (LMWH) for hemodialysis anticoagulation has been proposed as effective and safe for hemodialysis (HD) anticoagulation as standard unfractionated heparin (UFH). The aim of our study was to assess the use of LMWH for hemodialysis anticoagulation in comparison to UFH, including hemorrhagic events and clotting of the extracorporeal dialysis circuit and their effect on lipids profile. Methods: This prospective, randomized study conducted on 44 patients (31 males, 13 females; mean age 53.7.9±14.2 years) with end-stage renal disease on regular hemodialysis. The hemodialysis patients were subjected to UFH and followed prospectively for 16 weeks (48 dialyses sessions) and the same patients were subjected to LMWH (enoxaparin sodium; 40 mg) for a further 16 weeks, clotting of the extracorporeal dialysis circuit and hemorrhagic events were evaluated by visual inspection of the air trap, blood lines and dialyzers and the time required for arterio-venous fistula compression. Kt/V was calculated to determine whether UFH or LMWH had any effect on the adequacy of dialysis and lipid profile were measured at the end of each arm of the study to determine whether UFH or LMWH had any effect on the lipid profile levels. Results: The present study showed that, compared with UFH, the effect of LMWH (enoxaparin sodium) on the number of hemorrhagic events (relative risk, 1.3; 95% CI: 0.317 - 5.613; P=1.000) or clotting of the extracorporeal dialysis circuit (relative risk, 0.75; 95% CI: 0.284 - 1.984; P=1.000) was not significant. There was no significant difference in Kt/V between the UFH arm (1.4±0.4) and LMWH (enoxaparin sodium) arm (1.5±1.2; p=0.6). Also there was no significant differences in serum total Cholesterol, LDL, HDL and TGs between the UFH arm and LMWH (enoxaparin sodium arm). Conclusion: LMWH (Enoxaparin sodium) should be considered as effective and safe as unfractionated heparin in hemodialysis anticoagulation. But currently direct costs are about 26% more. So we recommend, the use of UFH for its low cost.
Authors and Affiliations
Emad Abdallah, Osama Mosbah, Ghada Khalifa
Keywords
Related Articles
- EP ID EP347180
- DOI 10.9734/BJMMR/2015/15365
- Views 66
- Downloads 0
Meta-analysis of Trials Comparing Drug-eluting Stents with Bare Metal Stents: Safety and Efficacy
Background: Effects of drug-eluting stents (DESs) on clinical outcomes as well as stent thrombosis are still under debate. Methods: Our meta-analysis included 26 randomized trials comparing DESs with bare metal stents (...
Ramadan Fasting and Maternal Perspectives in Healthy Pregnant Women: Systematic Review
Background: Practicing fasting during Ramadan by pregnant women might be risky. Controversies still exist about the nature and the magnitude of metabolic changes in healthy pregnant women who practice fasting. Objective...
Constructing a Structured Medical Presentation
Introduction: Giving presentation is an essential part in the medical practice. Physicians, in general are not expert in giving presentations, as it is not their daily practice. The weakness in conducting presentations c...
Comparative Study of Two Sclerosants for Pleurodesis for Incurable Pleural Effusions and Pneumothorax
Background: Pleurodesis is indicated in thoracic pathologies associated with pleural effusions or pneumothoraces resulting from incurable diseases and therefore risked with high chance of recurrence Objective: To compare...
Maternal and Fetal Outcome after Assisted Conception in Port Harcourt, Nigeria
Background: The introduction of assisted reproductive technology (ART) has played a major role in reducing the burden of infertility among couples. Although most pregnancies following assisted conception will progress no...